Showing 6,197 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Alcohol

Alcohol and HIV

About HIV
August 2025
Treatment guidelines

IAS 2025: Major updates to WHO guidelines: PrEP, injectable ART, infant feeding and prophylaxis and complications including mpox

Editor's pick
i-Base
9 August 2025
Adherence

Urine Tenofovir Rapid Assay Improves ART Adherence, Not HIV Viral Suppression

Editor's pick
Infectious Disease Advisor
9 August 2025
HIV treatment

US FDA Approves New Biktarvy Indication For People With HIV Who Are Treatment Experienced And Restarting Antiretroviral Treatment

Editor's pick
Gilead Sciences press release
4 August 2025
Treatment simplification strategies

Switching to dual ART after durable suppression in West and Central Africa

Editor's pick
i-Base
4 August 2025
Weight gain & lipodystrophy

Weight Gain Linked to Lower Quality of Life in HIV

Editor's pick
American Journal of Managed Care
4 August 2025
New & experimental HIV treatments

Ulonivirine Shows Promise for Weekly Oral HIV Treatment

Editor's pick
POZ
4 August 2025
Weight gain & lipodystrophy

GLP-1s and HIV: What You Need to Know Before Starting

Editor's pick
TheBody
4 August 2025
Injectable & long-acting PrEP

Lenacapavir PrEP ‘special cases’: young people, missed doses and drug interactions

News
30 July 2025
Weight gain & lipodystrophy

Weight Gain and HIV: It’s Not the Antiretrovirals, 3-Year Study Finds

Editor's pick
TheBodyPro
26 July 2025
Adherence

Taking drugs on time Illustrated

About HIV
July 2025
Viral load

Undetectable viral load Illustrated

About HIV
July 2025
Testing & health monitoring

Very recent infection Illustrated

About HIV
July 2025
Injectable & long-acting HIV treatment

Large, Diverse Study Backs Use of Long-Acting Injectable ART for Individuals With Viremia

Editor's pick
TheBodyPro
24 July 2025
Support issues for children & young people

New WHO guidance on HIV disclosure for children and adolescents

Editor's pick
World Health Organization
21 July 2025
Antibody-based treatment

Broadly neutralising antibodies plus immune modulator may delay HIV rebound

News
21 July 2025
Injectable & long-acting HIV treatment

Injectable HIV treatment works for people with poor HIV control in Africa

News
17 July 2025
Treatment simplification strategies

Intermittent HIV treatment dosing may be a response to the funding crisis, but adolescent study raises concerns

News
17 July 2025
Weight gain & lipodystrophy

Treatment changes do not reduce weight in people with HIV

News
17 July 2025
Injectable & long-acting HIV treatment

ViiV Healthcare and Medicines Patent Pool extend voluntary licensing agreement to enable access to long-acting injectable HIV treatment

Editor's pick
Medicines Patent Pool
15 July 2025
HIV treatment

How treatment works Illustrated

About HIV
July 2025
PEP

2025 Updates to US HIV nPEP Guidelines: Many Welcome Changes—and One Concern

Editor's pick
TheBodyPro
10 July 2025
Cardiovascular disease

Popular HIV Drug Linked to Higher Risk for MACE

Editor's pick
Medscape (requires free registration)
10 July 2025
New & experimental HIV treatments

U.S. FDA Accepts New Drug Application for Merck’s Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection

Editor's pick
Merck press release
10 July 2025